ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,849.72
      -1.76%
      US Tech 100
      19,882.00
      0.00%
      Dow Jones
      43,191.24
      -1.48%
      Brent Oil
      70.585
      -1.14%
      Bitcoin
      83,181.42
      -3.38%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Viracta Therapeutics Inc (VIRX) Quote

      Viracta Therapeutics Inc

      Viracta Therapeutics Inc (VIRX)

      Viracta Therapeutics Inc (PK)
      0.0301
      0.00
      (0.00%)
      Closed March 04 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.0301
      Bid
      0.0267
      Ask
      0.0367
      Volume
      -
      0.00 Day's Range 0.00
      0.0301 52 Week Range 1.31
      Market Cap
      1.196M
      Previous Close
      0.0301
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,367,441
      Shares Outstanding
      39,744,222
      Dividend Yield
      -
      PE Ratio
      -0.02
      Earnings Per Share (EPS)
      -1.28
      Revenue
      -
      Net Profit
      -51.06M

      About Viracta Therapeutics Inc

      Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.viracta.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Viracta Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRX. The last closing price for Viracta Therapeutics was $0.03. Over the last year, Viracta Therapeutics shares have traded in a share price range of $ 0.0301 to $ 1.31.

      Viracta Therapeutics currently has 39,744,222 shares outstanding. The market capitalization of Viracta Therapeutics is $1.20 million. Viracta Therapeutics has a price to earnings ratio (PE ratio) of -0.02.

      Ask ADVFN Intelligence (AI)

      VIRX Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 05 2025
      VIRX (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 31 2025
      VIRX (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 24 2025
      VIRX (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 17 2025
      VIRX (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      December 26 2024
      VIRX (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 29 2024
      VIRX (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 27 2024
      VIRX (0.00%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1000.03010.03010.030100CS
      4-0.0482-61.5581098340.07830.080.03014244120.0336039CS
      12-0.1336-81.61270616980.16370.2574060.030113674410.15933317CS
      26-0.1921-86.45364536450.22220.29720.030116686500.18090517CS
      52-0.9199-96.83157894740.951.310.03019936710.22940026CS
      156-2.8099-98.94014084512.845.750.03014369330.72389013CS
      260-16.7299-99.820405727916.7618.240.03013975572.0569835CS

      VIRX - Frequently Asked Questions (FAQ)

      What is the current Viracta Therapeutics share price?
      The current share price of Viracta Therapeutics is $ 0.0301
      How many Viracta Therapeutics shares are in issue?
      Viracta Therapeutics has 39,744,222 shares in issue
      What is the market cap of Viracta Therapeutics?
      The market capitalisation of Viracta Therapeutics is USD 1.2M
      What is the 1 year trading range for Viracta Therapeutics share price?
      Viracta Therapeutics has traded in the range of $ 0.0301 to $ 1.31 during the past year
      What is the PE ratio of Viracta Therapeutics?
      The price to earnings ratio of Viracta Therapeutics is -0.02
      What is the reporting currency for Viracta Therapeutics?
      Viracta Therapeutics reports financial results in USD
      What is the latest annual profit for Viracta Therapeutics?
      The latest annual profit of Viracta Therapeutics is USD -51.06M
      What is the registered address of Viracta Therapeutics?
      The registered address for Viracta Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
      What is the Viracta Therapeutics website address?
      The website address for Viracta Therapeutics is www.viracta.com
      Which industry sector does Viracta Therapeutics operate in?
      Viracta Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 73.90
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.30
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.75
      (0.00%)
      		0
      AACBUArtius II Acquisition Inc
      $ 10.03
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 73.90
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.30
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.75
      (0.00%)
      		0
      AACBUArtius II Acquisition Inc
      $ 10.03
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 73.90
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.30
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.75
      (0.00%)
      		0
      AACBUArtius II Acquisition Inc
      $ 10.03
      (0.00%)
      		0

      VIRX Discussion

      View Posts
      Renee Renee 4 weeks ago
      Yoiks....that was an important zeeeeero. Glad you caught it,
      👍️0
      trader59 trader59 4 weeks ago
      Left out a zero...
      $.0678
      👍️0
      Renee Renee 4 weeks ago
      VIRX: Delisted from the Nasdaq to the OTC. ***pps dropped 55% from ~.15 to .678 on 9+ million volume.

      https://otce.finra.org/otce/dailyList?viewType=Additions
      👍️0
      glenn1919 glenn1919 3 months ago
      VIRX.................................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Invest-in-America Invest-in-America 3 months ago
      VIRX: Up 35% in the Post-M today. (28-Mil. Float)
      👍️0
      TrendTrade2016 TrendTrade2016 4 months ago
      VIRX DILUTION HITTING HARD
      👍️0
      TrendTrade2016 TrendTrade2016 4 months ago
      VIRX ON THE MOVE
      👍️0
      Monksdream Monksdream 7 months ago
      VIRX new 52 week low
      👍️0
      glenn1919 glenn1919 7 months ago
      VIRX..............................................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Awl416 Awl416 7 months ago
      Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan
      👍️0
      glenn1919 glenn1919 11 months ago
      VIRX......................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 11 months ago
      VIRX under $2
      👍️0
      Monksdream Monksdream 1 year ago
      VIRX new 52 week low
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      https://stockcharts.com/h-sc/ui?s=virx&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      nice
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      lil dip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      soon
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      https://www.barchart.com/stocks/quotes/VIRX/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=VIRX&grid=1&height=500&studyheight=100
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      rip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      reasy
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      nice
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      dip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      dip
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      nice
      👍️0
      The Night Stalker The Night Stalker 2 years ago
      ready
      👍️0
      Triple nickle Triple nickle 2 years ago
      Break 1.81 and it’s boomage imo
      👍️0
      Triple nickle Triple nickle 2 years ago
      Could break out at 1.68 folks
      👍️0
      AOuvier AOuvier 3 years ago
      $VIRX- Took a starter position @ $5.01 today. Partial Order filled
      👍️0
      TheSilverFox121 TheSilverFox121 4 years ago
      WOW
      👍️0
      TheSilverFox121 TheSilverFox121 4 years ago
      Great to see some upwards strength! GLTA
      👍️0
      TheSilverFox121 TheSilverFox121 4 years ago
      I just bought in at 9.07 GLTA
      👍️0
      trity trity 4 years ago
      buy buy buy!!!!
      👍️0
      trity trity 4 years ago
      don't sell hold on to those shares
      👍️0
      trity trity 4 years ago
      fda may approve
      👍️0
      trity trity 4 years ago
      big news coming
      👍️0
      trity trity 4 years ago
      stock will jump big today
      👍️0
      John_Langston John_Langston 4 years ago
      Thanks
      👍️0
      Dspetry Dspetry 4 years ago
      On February 24, 2021, and in connection with the closing of the merger, Sunesis effected a 1-for-3.5 reverse stock split. All issued and outstanding shares of common stock of Sunesis were subject to the reverse stock split.
      👍️0
      John_Langston John_Langston 4 years ago
      What was the RS 1 for 3?
      👍️0
      Jconwon Jconwon 4 years ago
      Not even on anyone's radar. 16.25-18. rough 10% with almost no volume. Morning trade is good but hard to really predict these things.
      👍️0

      Your Recent History

      NASDAQ
      VIRX
      Viracta Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads